human | Q5 |
P496 | ORCID iD | 0000-0001-8250-1930 |
P108 | employer | University of Eastern Finland | Q2093139 |
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
Q45181384 | A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability |
Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
Q72427562 | A point mutation in the putative TATA box, detected in nondiseased individuals and patients with hereditary breast cancer, decreases promoter activity of the 17 beta-hydroxysteroid dehydrogenase type 1 gene 2 (EDH17B2) in vitro |
Q35870483 | A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients |
Q55043120 | A recurrent mutation in PALB2 in Finnish cancer families. |
Q72319861 | A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele |
Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
Q44443237 | A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. |
Q48410982 | Absence of association between an intercellular adhesion molecule 1 gene E469K polymorphism and Alzheimer's disease in Finnish patients |
Q61948755 | Abstract 3266: Expression quantitative trait locus analysis of triple negative breast cancer |
Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
Q53210396 | Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele. |
Q53348411 | An association between a subset of Finnish late-onset Alzheimer's disease and alpha2-macroglobulin. |
Q35681656 | Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis |
Q33947477 | Antenatal gene tests in low-risk pregnancies: molecular screening for aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL) in Finland |
Q73592923 | Antenatal genetic screening for congenital nephrosis |
Q73152217 | Apolipoprotein E alleles in women with intrahepatic cholestasis of pregnancy |
Q35399356 | Apolipoprotein E alleles in women with pre-eclampsia |
Q28216782 | Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease |
Q53202168 | Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland. |
Q53322695 | Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. |
Q41465811 | Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma |
Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
Q42718636 | Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary |
Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
Q46697376 | Beta-amyloid deposition in brains of subjects with diabetes |
Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
Q37406868 | Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions |
Q57305977 | Breast-Cancer Risk in Families With Mutations in PALB2 |
Q34148873 | Breast-cancer risk in families with mutations in PALB2 |
Q47719844 | Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients |
Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
Q52017293 | Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics. |
Q33677756 | Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility |
Q71041611 | Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism |
Q53305404 | Combined risk effects of IDE and NEP gene variants on Alzheimer disease. |
Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q30660858 | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
Q52054236 | Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. |
Q38354157 | Deletion in the FMR1 gene in a fragile-X male |
Q55110745 | E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. |
Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
Q53270093 | Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. |
Q51766497 | Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. |
Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
Q37394076 | FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome |
Q42683589 | FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population |
Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
Q51985838 | Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. |
Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q57305889 | Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q37369973 | Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes |
Q57278925 | Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas |
Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q57305903 | Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility |
Q54395614 | GASC1 expression in lung carcinoma is associated with smoking and prognosis of squamous cell carcinoma. |
Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
Q33589487 | Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes |
Q57305900 | Genetic Polymorphisms and Protein Expression of NRF2 and Sulfiredoxin Predict Survival Outcomes in Breast Cancer |
Q33197201 | Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. |
Q45279088 | Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease |
Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q43497584 | Genetic variation in apolipoprotein D and Alzheimer's disease |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q53349500 | Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland. |
Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
Q38823212 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk |
Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q53258567 | Heparan sulfate proteoglycan 2 polymorphism in Alzheimer's disease and correlation with neuropathology. |
Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
Q36547888 | Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers |
Q96821555 | High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival |
Q37121271 | High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium |
Q34475807 | Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer |
Q41483086 | Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay |
Q44168152 | Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
Q53341379 | Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination? |
Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q48087910 | Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects |
Q44430058 | Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer |
Q43075276 | Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in tRNAGln |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q43232447 | Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population |
Q53354359 | Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease. |
Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
Q44188638 | Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer's disease? |
Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
Q41581759 | KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes |
Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q48114226 | Linkage disequilibrium in the 13q12 region in Finnish late onset Alzheimer's disease patients |
Q36318321 | Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism |
Q35642678 | Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q47812698 | MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males |
Q58769239 | Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls |
Q51015419 | Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer. |
Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q47996260 | Microsatellite marker association at chromosome region 2p13 in Finnish patients with preeclampsia and obstetric cholestasis suggests a common risk locus |
Q44436193 | Midlife income, occupation, APOE status, and dementia: a population-based study |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q47989626 | Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia |
Q42706074 | MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen |
Q57232775 | Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q46567991 | NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer |
Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
Q33495389 | Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression |
Q34351474 | Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
Q36184231 | PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. |
Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
Q37307937 | Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium |
Q27851443 | Penetrance analysis of the PALB2 c.1592delT founder mutation |
Q36873786 | Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q36308550 | Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q34552678 | Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients |
Q47779309 | Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease |
Q53365689 | Possible association of nicastrin polymorphisms and Alzheimer disease in the Finnish population. |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q51973695 | Prenatal diagnosis of fragile X syndrome and the risk of expansion of a premutation. |
Q37350137 | Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups |
Q53337548 | Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals. |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
Q34425705 | RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability |
Q36009422 | RAD51B in Familial Breast Cancer |
Q48229615 | Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q28301674 | Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population |
Q49226587 | Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. |
Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
Q50849173 | SIP1 predicts progression and poor prognosis in pharyngeal squamous cell carcinoma. |
Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
Q33735332 | SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele |
Q42934843 | ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival |
Q34307873 | SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer? |
Q57278919 | Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families |
Q71675581 | Screening for amyloid beta precursor protein codon 665, 670/671 and 717 mutations in Finnish patients with Alzheimer's disease |
Q44070760 | Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease |
Q61118451 | Shared heritability and functional enrichment across six solid cancers |
Q64004349 | Shared heritability and functional enrichment across six solid cancers |
Q51006098 | Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism. |
Q33566957 | TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
Q35781316 | The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients |
Q36917100 | The UGT1A6_19_GG genotype is a breast cancer risk factor |
Q34144358 | The extent of linkage disequilibrium in four populations with distinct demographic histories |
Q35004850 | The gene for 17 beta-hydroxysteroid dehydrogenase maps to human chromosome 17, bands q12-q21, and shows an RFLP with ScaI. |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Q43850081 | Transcription factor snail1 expression and poor survival in pharyngeal squamous cell carcinoma |
Q33821467 | Transcription factors zeb1, twist and snai1 in breast carcinoma |
Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
Q33990838 | Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression |
Q34143985 | Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia |
Q92994868 | Two truncating variants in FANCC and breast cancer risk |
Q33910850 | Type II transmembrane serine protease gene variants associate with breast cancer |
Q50592574 | Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function. |
Q52052697 | Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. |
Q40706757 | Wide scope prenatal diagnosis at Kuopio University Hospital 1997-1998: integration of gene tests and fetal karyotyping |
Q57278886 | XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer |
Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Q28534781 | Γ-secretase components as predictors of breast cancer outcome |
Search more.